Pfizer Pharmaceutical Company: The World's Largest Pharmaceutical Company

Amy Schulman
Senior Vice President & General Counsel

Amy Schulman

Amy W. Schulman is Senior Vice President and the General Counsel of Pfizer. She leads the Company's worldwide Legal Division with responsibility for a range of global legal and regulatory areas, including intellectual property, litigation, regulatory law, global security, regulatory compliance, licensing and acquisitions.

Before joining Pfizer in June 2008, Ms. Schulman was a partner at DLA Piper, an international business law firm where she sat on the firm's Global Board, as well as the firm's Executive and Policy Committees. At DLA Piper, Ms. Schulman focused on complex class action litigation for numerous Fortune 500 clients. She has handled some of the most complicated legal, scientific and regulatory issues facing the world's most respected companies, including Pfizer. She also spearheaded a number of the firm's strategic initiatives, most notably in the areas of client services, diversity and inclusiveness, and mentoring.

Ms. Schulman, who has been recognized repeatedly for her commitment to clients and her skills as a legal advocate, was called "one of the best strategic lawyers around" by Chambers USA. In 2004, The American Lawyer recognized her as one of the legal superstars under the age of 45.

Ms. Schulman, who speaks and writes frequently on issues relating to women in the profession, mass tort and resolution strategies, was a Phi Beta Kappa graduate of Wesleyan University with a double major in Philosophy and English. She graduated from Yale Law School in 1989. Ms. Schulman is on the Board of Directors of Equal Justice Works and the Brooklyn Academy of Music.

Looking for a Pfizer Product?
A B-D E-H
I-N O-P R-Z
A-B C D-E
F-L M-P R-U V-Z
Interested in a Pfizer Career
Interested in a Pfizer Career?

Find out more about Pfizer career opportunities, search for current open positions, and submit your resumé online.

Pfizer Annual Report
Pfizer Annual Report

Learn more about our progress in building a foundation for solid, sustainable growth and
our promise to continue
as a leader in meeting
one of the world's most basic needs: better health care for more people.